Agenus Gross Profit vs Interest Income Analysis
AGEN Stock | USD 3.55 0.21 6.29% |
Agenus financial indicator trend analysis is way more than just evaluating Agenus Inc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Agenus Inc is a good investment. Please check the relationship between Agenus Gross Profit and its Interest Income accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Agenus Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
Gross Profit vs Interest Income
Gross Profit vs Interest Income Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Agenus Inc Gross Profit account and Interest Income. At this time, the significance of the direction appears to have very week relationship.
The correlation between Agenus' Gross Profit and Interest Income is 0.22. Overlapping area represents the amount of variation of Gross Profit that can explain the historical movement of Interest Income in the same time period over historical financial statements of Agenus Inc, assuming nothing else is changed. The correlation between historical values of Agenus' Gross Profit and Interest Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Gross Profit of Agenus Inc are associated (or correlated) with its Interest Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Interest Income has no effect on the direction of Gross Profit i.e., Agenus' Gross Profit and Interest Income go up and down completely randomly.
Correlation Coefficient | 0.22 |
Relationship Direction | Positive |
Relationship Strength | Very Weak |
Gross Profit
Gross profit is a required income statement account that reflects total revenue of Agenus Inc minus its cost of goods sold. It is profit before Agenus operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Interest Income
Income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments.Most indicators from Agenus' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Agenus Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Agenus Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. At this time, Agenus' Selling General Administrative is very stable compared to the past year. As of the 25th of November 2024, Issuance Of Capital Stock is likely to grow to about 136.4 M, while Sales General And Administrative To Revenue is likely to drop 0.48.
Agenus fundamental ratios Correlations
Click cells to compare fundamentals
Agenus Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Agenus fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 155.3M | 214.5M | 466.0M | 413.6M | 313.9M | 329.6M | |
Short Long Term Debt Total | 23.4M | 55.7M | 58.3M | 78.4M | 350.2M | 367.8M | |
Other Current Liab | 77.5M | 92.9M | 110.7M | 133.2M | 48.7M | 28.4M | |
Total Current Liabilities | 122.2M | 129.9M | 156.9M | 189.0M | 255.9M | 268.7M | |
Total Stockholder Equity | (225.4M) | (203.7M) | 34.4M | (61.3M) | (160.3M) | (152.3M) | |
Property Plant And Equipment Net | 33.7M | 60.3M | 91.1M | 164.3M | 163.0M | 171.2M | |
Net Debt | (38.4M) | (44.1M) | (233.6M) | (100.2M) | 274.1M | 287.8M | |
Retained Earnings | (1.3B) | (1.5B) | (1.5B) | (1.7B) | (2.0B) | (1.9B) | |
Accounts Payable | 13.6M | 17.0M | 30.5M | 40.9M | 61.4M | 64.5M | |
Cash | 61.8M | 99.9M | 291.9M | 178.7M | 76.1M | 71.1M | |
Non Current Assets Total | 68.8M | 100.7M | 134.0M | 200.4M | 201.5M | 211.6M | |
Non Currrent Assets Other | 1.4M | 4.1M | 9.5M | 4.5M | 5.7M | 3.5M | |
Cash And Short Term Investments | 61.8M | 99.9M | 306.9M | 193.4M | 76.1M | 81.2M | |
Common Stock Total Equity | 1.4M | 2.0M | 2.6M | 3.1M | 2.8M | 3.7M | |
Common Stock Shares Outstanding | 6.7M | 8.6M | 11.4M | 14.1M | 17.9M | 18.8M | |
Liabilities And Stockholders Equity | 155.3M | 214.5M | 466.0M | 413.6M | 313.9M | 329.6M | |
Non Current Liabilities Total | 264.5M | 296.1M | 261.1M | 279.5M | 206.4M | 113.2M | |
Other Current Assets | 1.0M | 2.0M | 3.2M | 3.2M | 10.5M | 11.0M | |
Other Stockholder Equity | 1.0B | 1.2B | 1.1B | 1.2B | 1.5B | 745.1M | |
Total Liab | 386.7M | 426.0M | 418.0M | 468.5M | 462.3M | 485.4M | |
Property Plant And Equipment Gross | 26.3M | 60.3M | 141.6M | 218.4M | 225.0M | 236.2M | |
Total Current Assets | 86.5M | 113.8M | 332.0M | 213.1M | 112.4M | 91.0M | |
Accumulated Other Comprehensive Income | (1.3M) | 2.8M | 1.5M | 915K | (955K) | (1.0M) | |
Short Term Debt | 2.0M | 2.8M | 3.4M | 2.5M | 145.7M | 153.0M | |
Common Stock | 1.4M | 2.0M | 2.6M | 3.1M | 3.9M | 3.7M | |
Other Liab | 216.1M | 216.2M | 205.9M | 191.3M | 220.0M | 231.0M | |
Other Assets | 1.4M | 37.6M | 9.5M | 4.5M | 4.0M | 3.1M | |
Long Term Debt | 13.4M | 18.9M | 12.8M | 12.6M | 12.8M | 12.1M | |
Net Receivables | 16.3M | 1.2M | 1.5M | 2.7M | 25.8M | 27.1M | |
Good Will | 23.2M | 25.5M | 24.9M | 25.5M | 24.7M | 23.5M | |
Inventory | 7.4M | 10.7M | 20.4M | 13.8M | 1.0 | 0.95 | |
Intangible Assets | 10.5M | 10.9M | 8.5M | 6.2M | 4.4M | 8.2M | |
Property Plant Equipment | 26.3M | 60.3M | 91.1M | 133.0M | 153.0M | 160.6M | |
Current Deferred Revenue | 29.2M | 17.2M | 12.4M | 12.3M | 18K | 17.1K | |
Net Tangible Assets | (21.0M) | (240.0M) | 1.1M | 159.2M | 183.1M | 192.3M | |
Noncontrolling Interest In Consolidated Entity | (6.0M) | (7.8M) | 13.5M | 6.4M | 7.3M | 7.7M | |
Retained Earnings Total Equity | (1.3B) | (1.5B) | (1.5B) | (1.7B) | (1.5B) | (1.6B) | |
Long Term Debt Total | 13.4M | 18.9M | 12.8M | 12.6M | 11.3M | 10.8M |
Pair Trading with Agenus
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Agenus position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agenus will appreciate offsetting losses from the drop in the long position's value.Moving together with Agenus Stock
0.86 | ME | 23Andme Holding | PairCorr |
0.76 | VALN | Valneva SE ADR | PairCorr |
0.85 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
Moving against Agenus Stock
0.59 | MDGL | Madrigal Pharmaceuticals | PairCorr |
0.54 | KZR | Kezar Life Sciences | PairCorr |
0.37 | RNXT | RenovoRx | PairCorr |
0.34 | MLYS | Mineralys Therapeutics, | PairCorr |
The ability to find closely correlated positions to Agenus could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Agenus when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Agenus - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Agenus Inc to buy it.
The correlation of Agenus is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Agenus moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Agenus Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Agenus can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Agenus Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agenus. If investors know Agenus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agenus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (11.02) | Revenue Per Share 7.808 | Quarterly Revenue Growth 0.033 | Return On Assets (0.22) | Return On Equity (12.79) |
The market value of Agenus Inc is measured differently than its book value, which is the value of Agenus that is recorded on the company's balance sheet. Investors also form their own opinion of Agenus' value that differs from its market value or its book value, called intrinsic value, which is Agenus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agenus' market value can be influenced by many factors that don't directly affect Agenus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agenus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Agenus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agenus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.